Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 2753X DABIGATRANdabigatran etexilate 110 mg capsule, 60 1 60 5
MPNP 9321N DABIGATRANdabigatran etexilate 110 mg capsule, 60 1 60 0
MPNP 2769R DABIGATRANdabigatran etexilate 150 mg capsule, 60 1 60 5
MPNP 9320M DABIGATRANdabigatran etexilate 75 mg capsule, 60 1 60 0
MPNP 9318K DABIGATRANdabigatran etexilate 75 mg capsule, 10 2 20 1
MPNP 9322P DABIGATRANdabigatran etexilate 75 mg capsule, 10 2 20 0
MPNP 9319L DABIGATRANdabigatran etexilate 110 mg capsule, 10 2 20 1
MPNP 9323Q DABIGATRANdabigatran etexilate 110 mg capsule, 10 2 20 0
MPNP 10645G DACLATASVIRdaclatasvir 30 mg tablet, 28 1 28 2
MPNP 10671P DACLATASVIRdaclatasvir 30 mg tablet, 28 1 28 5
MPNP 10642D DACLATASVIRdaclatasvir 60 mg tablet, 28 1 28 2
MPNP 10659B DACLATASVIRdaclatasvir 60 mg tablet, 28 1 28 5
MPNP 1229Q DALTEPARIN SODIUMdalteparin sodium 10 000 anti-Xa units/mL injection, 10 x 1 mL syringes 2 20 3
MPNP 8269F DALTEPARIN SODIUMdalteparin sodium 10 000 anti-Xa units/mL injection, 10 x 1 mL syringes 1 10 1
MPNP 8957K DALTEPARIN SODIUMdalteparin sodium 10 000 anti-Xa units/mL injection, 10 x 1 mL syringes 3 30 5
MPNP 1296F DALTEPARIN SODIUMdalteparin sodium 12 500 anti-Xa units/0.5 mL injection, 10 x 0.5 mL syringes 2 20 3
MPNP 5445N DALTEPARIN SODIUMdalteparin sodium 12 500 anti-Xa units/0.5 mL injection, 10 x 0.5 mL syringes 1 10 1
MPNP 8958L DALTEPARIN SODIUMdalteparin sodium 12 500 anti-Xa units/0.5 mL injection, 10 x 0.5 mL syringes 3 30 5
MPNP 2816F DALTEPARIN SODIUMdalteparin sodium 5000 anti-Xa units/0.2 mL injection, 10 x 0.2 mL syringes 2 20 0
MPNP 8642W DALTEPARIN SODIUMdalteparin sodium 5000 anti-Xa units/0.2 mL injection, 10 x 0.2 mL syringes 2 20 3
MPNP 8959M DALTEPARIN SODIUMdalteparin sodium 15 000 anti-Xa units/0.6 mL injection, 10 x 0.6 mL syringes 3 30 5
MPNP 8271H DALTEPARIN SODIUMdalteparin sodium 7500 anti-Xa units/0.75 mL injection, 10 x 0.75 mL syringes 1 10 1
MPNP 8643X DALTEPARIN SODIUMdalteparin sodium 7500 anti-Xa units/0.75 mL injection, 10 x 0.75 mL syringes 2 20 3
MPNP 8956J DALTEPARIN SODIUMdalteparin sodium 7500 anti-Xa units/0.75 mL injection, 10 x 0.75 mL syringes 3 30 5
MPNP 8960N DALTEPARIN SODIUMdalteparin sodium 18 000 anti-Xa units/0.72 mL injection, 10 x 0.72 mL syringes 3 30 5
MPNP 8603T DALTEPARIN SODIUMdalteparin sodium 2500 anti-Xa units/0.2 mL injection, 10 x 0.2 mL syringes 2 20 0
MPNP 8641T DALTEPARIN SODIUMdalteparin sodium 2500 anti-Xa units/0.2 mL injection, 10 x 0.2 mL syringes 2 20 3
MPNP 1780Q DANTROLENEdantrolene sodium hemiheptahydrate 50 mg capsule, 100 1 100 2
MPNP 1779P DANTROLENEdantrolene sodium hemiheptahydrate 25 mg capsule, 100 1 100 2
MPNP 10011X DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 1 28 5
MPNP 10510E DAPAGLIFLOZIN + METFORMINdapagliflozin 5 mg + metformin hydrochloride 1 g modified release tablet, 56 1 56 5
MPNP 10516L DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 500 mg modified release tablet, 28 1 28 5
MPNP 10515K DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 1 g modified release tablet, 28 1 28 5
MPNP 8801F DAPSONEdapsone 25 mg tablet, 100 1 100 1
MPNP 1272Y DAPSONEdapsone 100 mg tablet, 100 1 100 1
MPNP 5457F DENOSUMABdenosumab 60 mg/mL injection, 1 mL syringe 1 1 0
MPNP 10061M DENOSUMABdenosumab 120 mg/1.7 mL injection, 1.7 mL vial 1 1 5
MPNP 5110Y DENOSUMABdenosumab 120 mg/1.7 mL injection, 1.7 mL vial 1 1 5
MPNP 8663Y DESMOPRESSINdesmopressin acetate 200 microgram tablet, 30 1 30 5
MPNP 8712M DESMOPRESSINdesmopressin acetate 10 microgram/actuation nasal spray, 60 actuations 1 1 5
MPNP 9398P DESMOPRESSINdesmopressin 120 microgram sublingual wafer, 30 1 30 5
MPNP 8975J DESMOPRESSINdesmopressin 240 microgram sublingual wafer, 30 1 30 5
MPNP 10231L DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 1 28 5
MPNP 10245F DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 1 28 5
MPNP 9367B DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 1 28 5
MPNP 10234P DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 1 28 5
MPNP 10241B DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 1 28 5
MPNP 9366Y DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 1 28 5
MPNP 1288T DEXAMETHASONEdexamethasone 0.1% eye drops, 5 mL 1 1 2
MPNP 2507Y DEXAMETHASONEdexamethasone 4 mg tablet, 30 1 30 4
MPNP 1292B DEXAMETHASONEdexamethasone 500 microgram tablet, 30 1 30 4
MPNP 1291Y DEXAMETHASONE PHOSPHATEdexamethasone phosphate 8 mg/2 mL injection, 5 x 2 mL vials 1 5 1
MPNP 2509C DEXAMETHASONE PHOSPHATEDEXAMETHASONE SODIUM PHOSPHATE Injection equivalent to 4 mg dexamethasone phosphate in 1 mL, 5 1 5 0
MPNP 3472R DEXAMETHASONE PHOSPHATEDEXAMETHASONE SODIUM PHOSPHATE Injection equivalent to 4 mg dexamethasone phosphate in 1 mL, 5 1 5 0
MPNP 1165H DEXAMFETAMINEdexamfetamine sulfate 5 mg tablet, 100 1 100 5
MPNP 1509K DEXTRAN-70 + HYPROMELLOSEdextran-70 0.1% + hypromellose 0.3% eye drops, 15 mL 1 1 5
MPNP 8299T DEXTRAN-70 + HYPROMELLOSEdextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL unit doses 3 3 5
MPNP 3161J DIAZEPAMdiazepam 2 mg tablet, 50 1 50 0
MPNP 5355W DIAZEPAMdiazepam 2 mg tablet, 50 1 50 3
MPNP 2558P DIAZEPAMdiazepam 10 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 3458B DIAZEPAMdiazepam 10 mg/2 mL injection, 5 x 2 mL ampoules 1 5 0
MPNP 2669L DIAZEPAMdiazepam 1 mg/mL oral liquid, 100 mL 1 1 0
MPNP 3162K DIAZEPAMdiazepam 5 mg tablet, 50 1 50 0
MPNP 5356X DIAZEPAMdiazepam 5 mg tablet, 50 1 50 3
MPNP 1300K DICLOFENACdiclofenac sodium 50 mg enteric tablet, 50 1 50 3
MPNP 5362F DICLOFENACdiclofenac sodium 50 mg enteric tablet, 50 1 50 3
MPNP 1299J DICLOFENACdiclofenac sodium 25 mg enteric tablet, 50 2 100 3
MPNP 5361E DICLOFENACdiclofenac sodium 25 mg enteric tablet, 50 2 100 3
MPMWNP 1302M DICLOFENACdiclofenac sodium 100 mg suppository, 20 2 40 3
MPNP 5363G DICLOFENACdiclofenac sodium 100 mg suppository, 20 2 40 3
MPMWNP 8121K DICLOXACILLINdicloxacillin 250 mg capsule, 24 1 24 0
MPMWNP 8122L DICLOXACILLINdicloxacillin 500 mg capsule, 24 1 24 0
MPNP 3164M DIGOXINdigoxin 50 microgram/mL oral liquid, 60 mL 2 2 3
MPNP 2605D DIGOXINdigoxin 62.5 microgram tablet, 200 1 200 1
MPNP 1322N DIGOXINdigoxin 250 microgram tablet, 100 1 100 1
MPNP 1313D DILTIAZEMdiltiazem hydrochloride 240 mg modified release capsule, 30 1 30 5
MPNP 8480H DILTIAZEMdiltiazem hydrochloride 360 mg modified release capsule, 30 1 30 5
MPNP 1312C DILTIAZEMdiltiazem hydrochloride 180 mg modified release capsule, 30 1 30 5
MPNP 1335G DILTIAZEMdiltiazem hydrochloride 60 mg tablet, 90 1 90 5
MPNP 2501P DIPHENOXYLATE + ATROPINE SULFATE MONOHYDRATEdiphenoxylate hydrochloride 2.5 mg + atropine sulfate monohydrate 25 microgram tablet, 20 1 20 0
MPNP 3463G DIPHTHERIA TOXOID + TETANUS TOXOIDdiphtheria toxoid 2 international units/0.5 mL + tetanus toxoid 20 international units/0.5 mL injection, 5 x 0.5 mL syringes 2 10 0
MPNP 8783G DIPHTHERIA TOXOID + TETANUS TOXOIDdiphtheria toxoid 2 international units/0.5 mL + tetanus toxoid 20 international units/0.5 mL injection, 5 x 0.5 mL syringes 1 5 0
MPNP 8335Q DIPYRIDAMOLEdipyridamole 200 mg modified release capsule, 60 1 60 5
MPNP 8382E DIPYRIDAMOLE + ASPIRINdipyridamole 200 mg + aspirin 25 mg modified release capsule, 60 1 60 5
MPNP 2923W DISOPYRAMIDEdisopyramide 100 mg capsule, 100 1 100 5
MPNP 10040K DOCOSAHEXAENOIC ACID WITH CARBOHYDRATEdocosahexaenoic acid with carbohydrate containing 200 mg docosahexaenoic acid oral liquid: powder for, 30 x 4g sachets 4 4 5
MPNP 1347X DOMPERIDONEdomperidone 10 mg tablet, 25 1 25 0
MPNP 2532G DONEPEZILdonepezil hydrochloride 5 mg tablet, 28 1 28 5
MPNP 8495D DONEPEZILdonepezil hydrochloride 5 mg tablet, 28 1 28 5
MPNP 2479L DONEPEZILdonepezil hydrochloride 10 mg tablet, 28 1 28 5
MPNP 8496E DONEPEZILdonepezil hydrochloride 10 mg tablet, 28 1 28 5
MPNP 1358L DOSULEPIN (DOTHIEPIN)dosulepin (dothiepin) hydrochloride 75 mg tablet, 30 1 30 2
MPNP 1357K DOSULEPIN (DOTHIEPIN)dosulepin (dothiepin) hydrochloride 25 mg capsule, 50 1 50 2
MPNP 1011F DOXEPINdoxepin 10 mg capsule, 50 1 50 2
MPNP 1012G DOXEPINdoxepin 50 mg tablet, 50 1 50 2
MPNP 1013H DOXEPINdoxepin 25 mg capsule, 50 1 50 2
MPNP 2715X DOXYCYCLINEdoxycycline 100 mg modified release capsule, 21 1 21 0
MPNP 2711Q DOXYCYCLINEdoxycycline 50 mg tablet, 25 1 25 5
MPNP 9106G DOXYCYCLINEdoxycycline 50 mg tablet, 25 1 25 5
MPNP 10176N DOXYCYCLINEdoxycycline 100 mg tablet, 21 1 21 0
MPNP 1800R DOXYCYCLINEdoxycycline 100 mg tablet, 21 1 21 0
MPNP 2708M DOXYCYCLINEdoxycycline 100 mg modified release capsule, 7 1 7 1
MPNP 2703G DOXYCYCLINEdoxycycline 100 mg modified release capsule, 7 4 28 0
MPNP 2707L DOXYCYCLINEdoxycycline 50 mg modified release capsule, 25 1 25 5
MPNP 2702F DOXYCYCLINEdoxycycline 100 mg tablet, 7 4 28 0
MPNP 2709N DOXYCYCLINEdoxycycline 100 mg tablet, 7 1 7 1
MPNP 2714W DOXYCYCLINEdoxycycline 100 mg tablet, 7 3 21 0
MPNP 9105F DOXYCYCLINEdoxycycline 100 mg tablet, 7 1 7 1
MPNP 9107H DOXYCYCLINEdoxycycline 100 mg tablet, 7 4 28 0
MPNP 9108J DOXYCYCLINEdoxycycline 100 mg tablet, 7 3 21 0
MPNP 11364D DULAGLUTIDEdulaglutide 1.5 mg/0.5 mL injection, 4 x 0.5 mL injection devices 1 4 5
MPNP 9155W DULOXETINEduloxetine 30 mg enteric capsule, 28 1 28 0
MPNP 9156X DULOXETINEduloxetine 60 mg enteric capsule, 28 1 28 5
MPNP 5468T DUTASTERIDEdutasteride 500 microgram capsule, 30 1 30 5
MPNP 5490Y DUTASTERIDE + TAMSULOSINdutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 1 30 5